Aktive Positionen von Ram Kamineni
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KRYSTAL BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 01.07.2022 | - |
Karriereverlauf von Ram Kamineni
Ehemalige bekannte Positionen von Ram Kamineni
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KVK-Tech, Inc.
KVK-Tech, Inc. Pharmaceuticals: MajorHealth Technology KVK-Tech, Inc. is a pharmaceutical company based in the United States, specifically in Newtown, PA. The private company specializes in the development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs. KVK-Tech handles all aspects of the manufacturing process, including packaging, distribution, research and development, and customer service. The company's portfolio includes a range of generic drugs that are chemically identical to branded drugs and must meet the same strict standards to receive FDA approval. KVK-Tech has a vision for 2020 to manufacture high-quality, affordable generics in every major dosage form. The CEO of the company is Anthony Tabasso. | Chief Operating Officer | 01.04.2021 | 01.10.2021 |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
KRYSTAL BIOTECH, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
KVK-Tech, Inc.
KVK-Tech, Inc. Pharmaceuticals: MajorHealth Technology KVK-Tech, Inc. is a pharmaceutical company based in the United States, specifically in Newtown, PA. The private company specializes in the development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs. KVK-Tech handles all aspects of the manufacturing process, including packaging, distribution, research and development, and customer service. The company's portfolio includes a range of generic drugs that are chemically identical to branded drugs and must meet the same strict standards to receive FDA approval. KVK-Tech has a vision for 2020 to manufacture high-quality, affordable generics in every major dosage form. The CEO of the company is Anthony Tabasso. | Health Technology |
- Börse
- Insiders
- Ram Kamineni
- Erfahrung